In a given population the age pattern of mortality is an important determinant of total number of deaths, age structure, and through effects on age structure, the number of births and thereby growth. Good mortality models exist for most populations except those experiencing generalized HIV epidemics and some developing country populations. The large number of deaths concentrated at very young and adult ages in HIV-affected populations produce a unique ‘humped’ age pattern of mortality that is not reproduced by any existing mortality models. Both burden of disease reporting and population projection methods require age-specific mortality rates to estimate numbers of deaths and produce plausible age structures. For countries with generalized HIV epidemics these estimates should take into account the future trajectory of HIV prevalence and its effects on age-specific mortality. In this paper we present a parsimonious model of age-specific mortality for countries with generalized HIV/AIDS epidemics.
Methods and Findings
The model represents a vector of age-specific mortality rates as the weighted sum of three independent age-varying components. We derive the age-varying components from a Singular Value Decomposition of the matrix of age-specific mortality rate schedules. The weights are modeled as a function of HIV prevalence and one of three possible sets of inputs: life expectancy at birth, a measure of child mortality, or child mortality with a measure of adult mortality. We calibrate the model with 320 five-year life tables for each sex from the World Population Prospects 2010 revision that come from the 40 countries of the world that have and are experiencing a generalized HIV epidemic. Cross validation shows that the model is able to outperform several existing model life table systems.
We present a flexible, parsimonious model of age-specific mortality for countries with generalized HIV epidemics. Combined with the outputs of existing epidemiological and demographic models, this model makes it possible to project future age-specific mortality profiles and number of deaths for countries with generalized HIV epidemics.
Citation: Sharrow DJ, Clark SJ, Raftery AE (2014) Modeling Age-Specific Mortality for Countries with Generalized HIV Epidemics. PLoS ONE 9(5): e96447. https://doi.org/10.1371/journal.pone.0096447
Editor: Andrew Noymer, University of California, United States of America
Received: July 25, 2013; Accepted: April 8, 2014; Published: May 22, 2014
Copyright: © 2014 Sharrow et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants R01 HD054511, R01 HD070936, and K01 HD057246 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The age pattern of mortality is a reflection of the age-specific underlying killing mechanisms and epidemiological profile of a population. Numerous mortality indicators like the under five mortality rate (the probability of death between birth and age 5, referred to as U5MR or ) or the adult mortality rate (the probability that a 15 year old will die before reaching age 60 or ) that are regularly used to track population health and development goals are often calculated from a complete set of age-specific period mortality rates. Moreover, for many countries without adequate vital registration systems, the total number of deaths in a population (the so-called ‘envelope’) used to allocate deaths by cause in global health reporting, such as the global burden of disease studies , , is calculated using model life tables to estimate all-cause mortality, and hence the total number of deaths. Accurate estimation of these age patterns is an essential step toward monitoring population wellbeing and working toward targeted public health actions.
Unfortunately, less than half the world’s countries have civil vital registration systems that function well enough to accurately count people and deaths by sex and age and thereby produce reliable measures of sex-age-specific mortality , . This issue is particularly relevant to most countries experiencing high HIV prevalence. In the absence of this information, analysts use model life tables or other model-based approaches to estimate complete sets of sex-age-specific mortality rates based on a small number of mortality indictors such as life expectancy at birth or the U5MR. None of the existing model life tables are suitable for estimating mortality patterns for high HIV prevalence countries because they were not designed to reproduce the unique age pattern of deaths associated with HIV. HIV predominantly infects infants (from their mother) and young/middle-aged adults. Combined with the characteristic survival times for HIV children and adults, this age pattern of incidence results in deaths concentrated in very young children and middle-aged adults. The result for the age profile of mortality is a spike in child mortality and a ‘hump’ in adult mortality located roughly in the middle of life –.
The impact of endemic HIV on the age pattern of mortality is illustrated in Figure 1, which plots the five-year female mortality rate schedules from 1970–2010 for the 40 countries of the world experiencing a generalized HIV epidemic . The mortality rate schedules produced under a generalized epidemic are plotted in red. A “generalized” HIV epidemic is defined by HIV prevalence greater than 1% in the general population and no concentration of the epidemic in high-risk subgroups such as men who have sex with men, intravenous drug users, or sex workers and their clients (From , p. 523): “Large increases in mortality associated with HIV/AIDS are observed in countries where prevalence in the general population is greater than about 1%. A stationary population with an expectation of life of 10 years, similar to the HIV-positive population, has a crude death rate of 1/10 = 0.1 or 100 per 1,000. A population containing 1% HIV-positive people will therefore add about 1 additional death per 1,000 to the crude death rate. Consequently, for populations with baseline (non-HIV) crude death rates of 10 per 1,000, an HIV prevalence of 1% corresponds to a significant 10% increase in the overall crude death rate.” Figure 1 clearly shows the accentuated adult mortality hump characteristic of generalized epidemics. Existing models of age-specific mortality and model life table systems have considerable trouble replicating the mortality profile generated under high HIV prevalence , . Figure 2 plots the age-specific mortality rates for Lesotho females 2005–2010 (HIV prevalence 24% during this period and the previous five year period in Lesotho) along with the fits from four existing models: Coale and Demeny regional model life tables , , UN model life tables for developing countries , WHO modified logit model , and a recent and in many instances, remarkably accurate log-quadratic model based on data from the Human Mortality Database advanced by Wilmoth and colleagues , referred to as ‘Log-Quad’ in the remainder of this paper. Instead of fitting the hump itself, these models tend to produce a high, flat pattern of mortality that often matches the overall level of mortality, as measured by life expectancy at birth, but misses the actual age-specific rates. These fits do not reflect methodological shortcomings of any of these models but rather show that despite being the most widely used and accurate models of this type, they were not calibrated with data from high HIV prevalence countries/periods and are thus not designed to fit this type of pattern.
–axis on log scale. Country-periods with a generalized epidemic (>1% HIV prevalence) plotted in red.
1) HIV prevalence with life expectancy at birth [solid black line] 2) HIV prevalence and child mortality [dotted black line] 3) HIV prevalence with child mortality and adult mortality [dashed black line]. For comparison, fits from the WHO modified logit model [red solid line], Coale and Demeny model life tables [green solid line], UN model life tables for developing countries [teal solid line], and the Log-Quad model [purple solid line] are also shown.
Model life tables also play a critical role in population projections. The United Nations Population Division (UNPD) produces population projections broken down by sex and age for all countries of the world every two years in the World Population Prospects. Although several organizations produce population projections, the UN projections have become the de facto standard ,  and are used by international organizations and many governments whose statistical offices do not regularly produce such estimates and projections, a group that includes some of the high HIV prevalence countries. The UNPD’s current population projection methodology requires that age-specific mortality, fertility, and international migration rates be projected for each five-year period in the future. To obtain future mortality rates for countries not experiencing endemic HIV, the five-year gains in life expectancy at birth, , are projected  and then converted to age-specific rates based on model mortality patterns such as those contained in existing model life table systems. Age-specific mortality rates, especially during the course of an HIV epidemic, play a key role in future population size and age composition. Thus, the mortality component of projections for countries with generalized epidemics should include the influence of the future trajectory of the HIV epidemic and be able to produce the heavy adult mortality resulting from HIV/AIDS-related deaths.
We present an HIV prevalence-calibrated model of sex-age-specific mortality that produces a complete set of sex-age-specific mortality rates as a function of HIV prevalence and one of three possible sets of additional inputs: life expectancy at birth, child mortality alone, or child mortality and adult mortality.
This objective and many of its detailed requirements are shaped by our ongoing collaboration with the UNPD to develop methods for probabilistic population estimation and projection , –. Consequently this HIV-calibrated model life table system is specifically designed to work well within the UNPD’s evolving population projection method. Current epidemiological and demographic models ,  can make probabilistic projections of the key inputs. The mortality model presented here makes it possible to convert those inputs into probabilistic projections of age-specific mortality rates for countries with generalized HIV epidemics.
The empirical base needed for this work is a comprehensive set of sex-age-specific mortality rates from populations with varying HIV prevalence that also span a wide range of HIV epidemic ages – i.e. ‘new’ to ‘old’ epidemics. While the need for variation in prevalence is obvious, the need for different epidemic ages arises from the changing dynamics of an epidemic as it ages and the fact that the characteristic age pattern of HIV incidence, prevalence, and mortality change as an epidemic ages and experiences interventions such as widespread use of antiretroviral therapy (ART). Sufficient empirical data fitting these requirements do not exist in a vetted, corrected, pooled, organized, documented fashion that can be used for a project such as this. The UNPD and many other potential users urgently need a new mortality model for populations with high HIV prevalence. Given these important needs, we have adopted a compromise solution that should work well enough for most purposes and is certainly better than having no HIV-calibrated model life table system. Our compromise is to use the set of life tables produced by the UNPD for countries with high HIV prevalence as part of their 2010 revision of the World Population Prospects . The variation in age patterns of mortality in this collection of life tables is a systematic representation of what is known about HIV and mortality in populations with generalized epidemics. Furthermore, although not strictly empirical, this collection of life tables is empirically-based and uses most of the information we have on the effects of HIV on mortality by sex, age, HIV prevalence, and HIV epidemic stage (or age). We say ‘most of the information’ as the UNPD collection does not make systematic use of empirical data from demographic surveillance systems (DSS) such as those in the INDEPTH network (http://www.indepth-network.org/), HIV surveillance systems such as those from the ALPHA network (http://www.lshtm.ac.uk/eph/dph/research/alpha/), or certain sub-national surveys. Likewise, we refer to these data as ‘empirically-based’ in the sense that they are constructed from our best estimates of HIV prevalence and mortality and constrained to be consistent with long-term changes in population age structure, fertility, and mortality. These data are still not truly empirical, but they are the best we can do without embarking on a major data acquisition project. The structure and mechanics of the model we describe below do not depend on the data used to calibrate the model, so when a better, more empirical data set is available, it will be a straightforward task to recalibrate the model using the new data.
Resulting from the current unavailability of truly empirical data, we calibrate our model using a set of 320 five-year life tables for each sex from the World Population Prospects 2010 revision . This dataset represents the 40 countries of the world experiencing a generalized HIV epidemic with eight five-year life tables from 1970–2010 for each country.
From the life tables we model the age-specific mortality rates ( or the mortality rate from age to ) and derive the life expectancy at birth, child mortality ( or the probability a newborn will die before his or her fifth birthday), and adult mortality ( or the probability that a 15 year old will die before reaching his or her 60th birthday). The female log age-specific mortality rates are plotted for each country and time period in Figure 1. All life tables have uniform five-year age intervals except for the youngest age groups, up to an open interval of 100+ (0, 1–4, 5–9, 10–14,…, 100+). Finally, we obtain the mid-period (1973, 1978, 1983,…, 2008) HIV prevalence for adults age 15–49 as well as adult and child antiretroviral therapy (ART) coverage for each of the 320 country-periods from UNPD estimates used to produce WPP 2010 .
Our objective is a parsimonious model that can represent the age pattern of mortality rates for countries with generalized HIV epidemics as a function of HIV prevalence and some other mortality indicator (, alone, or with ). To accomplish this objective, we extend the component model of mortality that we developed earlier ,  to include covariates, in this case HIV prevalence and various mortality indicators. As in  the general form of the model represents a set of age-specific mortality rates as the weighted sum of three independent, age-varying components that represent the age-varying nature of the mortality schedule:(1)where is the period age-specific mortality rate from age to age for life table , is a constant specific to life table , is the value of the th component for age , is the weight of the th component for life table , and is the error term. The age-varying components are fixed. Thus, the effective parameters in this model are the component weights , which are modeled as a function of HIV prevalence and an overall mortality indicator.
We first derive the age-varying components from a Singular Value Decomposition (SVD) of the matrix of observed mortality rate schedules. SVD decomposes a matrix into three smaller matrices including one whose columns are orthogonal and point in the directions with most variation in the original (22-dimensional) space – the left singular vectors (LSVs). The LSVs plotted in Figure 3 (and presented in Table S1) are the independent components we need, and they have the convenient property of encoding the bulk of the variation among the observed mortality schedules in a small number of vectors. We performed an in-sample validation similar to that outlined in the ‘Model Validation’ section using the model with a varying number of components and found little improvement in fit when including more than three components. The lack of improvement with inclusion of higher order components reflects the fact that each successive LSV accounts for a successively smaller proportion of the overall variance; the first three LSVs account for roughly 99.6% of the total age variation.
Derived from the Singular Value Decomposition of the World Population Prospects five-year mortality rate schedules 1970–2010 for countries with generalized HIV epidemics. from Equation 1.
Following Clark ,  we next regress each of the 320 mortality rate schedules for each sex on the first three left-singular vectors from the SVD yielding a set of weights , ordinary least squares regression coefficients, for each country-period life table. These weights relate the individual mortality rate schedule to the SVD components. Again using ordinary least squares, each is modeled as a linear combination of HIV prevalence and one of three sets of mortality indictors: life expectancy at birth, child mortality alone, or child mortality and adult mortality. We use Bayesian model selection  to find the combination of these variables that best explains each (this step was performed using the BMA package  in the statistical analysis software R). In model selection we included ART coverage for both adults and children among the set of potential predictor variables along with HIV prevalence and the mortality indicator, but neither adult nor child ART coverage was found to predict the weights.
We fit separate models for each by sex as well as for African countries and non-African countries (Bahamas, Belize, Guyana, Haiti, and Jamaica). The region-sex-specific model coefficients for each are given in Tables S2, S3, and S4. Using the coefficients presented in these tables, for a given HIV prevalence and value(s) of one of the three mortality input combinations, one can produce predicted values of , denoted by , which when substituted into Equation 1 produce a set of predicted mortality rates.
Finally, we adjust the predicted mortality rates so that the mortality indicators output from the model match the input values. When the input indicator is life expectancy at birth, we adjust in Equation 1 in such a way that the output mortality rates produce a life expectancy that matches the input life expectancy. This adjustment typically alters the level of mortality rather than its shape because the pattern of predicted mortality rates is largely determined by the ’s. When the input indicator is child mortality alone, we raise the first two mortality rates, and , to the power , where is the solution to the equation:(2)namely . When child mortality and adult mortality are used as the inputs, we use a combination of the two adjustments just described. We adjust to match as we did with and then match using Equation 2. In practice, the predicted rates typically need very little adjustment, but this approach ensures that the output mortality indicators match the inputs.
Our Model in Relation to Existing Mortality Models
We now describe how our model compares to existing mortality models that also use matrix factorization to generate reference age patterns.
The SVD is a general linear algebra technique used to factor an arbitrary rectangular matrix into three new matrices related to each other by the product . Intuitively, imagine the column vectors of as a cloud of points; the SVD identifies a new orthonormal basis (the right singular vectors ) for this cloud. The singular values (diagonal matrix ) indicate the characteristic magnitude of the cloud in the direction of each new dimension. The product of the singular values and the left singular vectors () locate each point along the new dimensions. SVD does not require the cloud to be centered (mean-subtracted), and consequently, in general the new basis identified by SVD does not line up with the axes of maximum variation in the cloud.
Principal Components Analysis (PCA) is a related technique that is equivalent to a specific application of SVD. PCA aims to identify the axes of maximum variation in a cloud of data points. It does this by finding the eigen decomposition of the covariance (or correlation) matrix associated with the data. The covariance matrix is a description of a centered version of the data and also square; eigen decomposition requires a well-behaved square matrix. PCA is equivalent to an SVD on a centered version of the data; in this specific circumstance, the eigenvectors and right singular vectors identify the same orthogonal axes along which there is maximum variation in the cloud of data points, and the square roots of the eigenvalues are equal to the singular values.
Several mortality models use factorization methods like SVD and PCA to represent aspects of the age pattern of mortality. The Lee-Carter model  uses an SVD factorization of mean-substracted, logged age-specific mortality rates to provide the age-specific components of the model ( and in Section 3, p 661 of ) and the Log-Quad model  uses an SVD factorization to extract the characteristic age-pattern (the first LSV) from the residuals produced from fitting the model without the ‘’ correction component (Equation A6, p 28 of ). This age pattern of residuals is then scaled using the ‘’ correction parameter in the model. The UN model life tables for developing countries  also use PCA to depict the age pattern of mortality change within regional clusters.
Although our model also uses an SVD factorization, the structure of our model is different from other mortality models, including the three just mentioned, and the SVD-derived components are both different and incorporated in a new way. Our model does not have families like the UN model life tables, does not use SVD-like components to model residuals like either the Log-Quad or UN model life tables, and does not incorporate a particular functional form like the Log-Quad model. Our model is most similar to the Lee-Carter model but differs in important ways. The Lee-Carter model uses the SVD to factorize the mean-subtracted log mortality rates (like a PCA) into a component that represents the basic age pattern of mortality and a second component that represents time-dependent, age-specific changes in mortality. Unlike all the others discussed here, including ours, the Log-Quad model exploits the general curvilinear relationship between child mortality and mortality at older ages and builds this relationship into the model so that non-child mortality is a quadratic function of child mortality. The SVD-derived ‘’ correction component is used to ensure that the age pattern of non-child mortality is reasonable (and flexible); essentially it implements an age-specific fine-tuning of the fundamental prediction of non-child mortality from child mortality.
Our model is simpler in its general form and designed to be able to incorporate any collection of possible predictors. We use the SVD to factorize observed log mortality (without subtracting the mean, i.e. unlike PCA) into 1) a basic age pattern of log mortality and 2) additional orthogonal components that represent age patterns of deviation from the basic pattern, where is the number of life tables in the dataset. These factors are the LSVs, and we find that three are sufficient to reproduce the important age-based variation in the data. Any of the observed age patterns of mortality in the original dataset can be reproduced to within desired precision by taking a weighted sum of enough components. Unlike the other models described, we further model the weights of the three components that we keep as linear functions of HIV prevalence and various indicators of mortality level (, and/or ). Operating through the weights, these parameters adjust both level and shape simultaneously to produce a continuously varying series of life tables. So although we use some of the same ingredients, our model is conceptually and operationally distinct from existing mortality models.
HIV prevalence for the African life tables ranges from 0 to 26% with a mean of 3.7%, while for the non-African life tables prevalence is much lower overall, ranging from 0 to 3.8% with a mean of 1.3%. Likewise, life expectancy among the African life tables is considerably lower than for the five non-African countries. African male life expectancy ranges from approximately 22 to 62 years with a mean of 48.3, and African female life expectancy ranges from 25.6 to 65.8 with a mean of 51.1. Male life expectancy from the non-African countries ranges from 46.7 to 74 with a mean of 64, and female non-African life expectancy ranges from 49.3 to 77.8. These differences in the distributions of the input parameters are what drives the need for region-sex-specific models and are reflected in the region-specific distribution of weights . A summary of the values for African and non-African life tables is shown in Table 1. Note the overall lower distribution of the first weight for African countries. When multiplied by the first LSV (red line plotted in Figure 3), which has negative values at all ages, the smaller African weights produce a higher overall level of mortality, which is then altered in a life expectancy-constant way to reflect the influence of HIV prevalence on the age pattern of mortality.
The output from this model is a complete set of predicted log sex-age-specific mortality rates that reflect HIV prevalence and can be used to calculate a full life table from which various mortality indictors can be generated. The effective parameters are the weights derived from region- and sex-specific models. The model will produce a full set of sex-age-specific mortality rates for any combination of HIV prevalence and mortality indicator – life expectancy at birth, child mortality alone or child mortality with adult mortality.
Model outputs for various combinations of HIV prevalence and life expectancy for Africa are presented in Figures 4 and 5 for females and males respectively. Figures 4 and 5 illustrate the range of patterns our model can produce and reveal another desirable property of this model. ART coverage is not related to (does not predict) the weights , but the effect of ART on adult mortality is not ignored. Once ART coverage reaches near universal levels, a paradox emerges in which both life expectancy and HIV prevalence increase together as seropositive individuals live longer in the population and the HIV mortality hump is pushed to older and older ages, eventually merging with the natural increase in mortality at advanced ages –. The model must be able to represent this relationship in the future. Figures 4 and 5 confirm that the model can do this. At higher levels of life expectancy, the effect of prevalence is mitigated and the adult mortality hump nearly disappears, even at very high prevalence.
In order to evaluate prediction accuracy and the robustness of our modeling strategy, we carried out a cross validation exercise where we calibrated the model (for all three input combinations) with a random 75% sample of the data, and then predicted the remaining 25%. We ascertained fit by calculating the mean absolute error (MAE) for the (non-logged) mortality rates among all age groups (0–75) and life tables in the prediction sample along with the MAE for life expectancy at birth , under-5 mortality , and adult mortality . For comparison with existing models of all-age mortality, we predicted the 25% held-out sample using the WHO modified logit system, the UN model life tables for developing countries, the Coale-Demeny regional model life tables, and the Log-Quad model. The UN system was fit using the procedure described on page 2 of Chapter IV of , Model Life Tables for Developing Countries, where the complete set of age-specific probabilities of death is used to estimate the appropriate loading factor. To fit the Coale and Demeny life tables, we first selected the level by matching life expectancy to the closest half year and then selected the regional pattern that minimizes the sum of squared errors from the observed mortality rates. The WHO system was fit using the STATA software inputing , survivorship to age 5, and , survivorship to age 60, to the “modmatch” function obtained from http://www.who.int/healthinfo/global_burden_disease/tools_software/en/. The Log-Quad model was fit with R code provided at http://www.demog.berkeley.edu/~jrw/LogQuad/ and takes and as inputs. Repeating this procedure 1,000 times yields a distribution of these fit metrics. The means of these distributions are presented in Table 2. Because the system described in this paper is essentially an HIV-calibrated model life table system we refer to it as ‘HIV MLT’. For all metrics, smaller numbers suggest a better overall fit and the smallest number in each column is bolded.
Results from Table 2 show that our model is able to outperform the other four existing model life table systems when fitting mortality data generated under high HIV prevalence. This result is no surprise because those models were not designed to replicate the age pattern of mortality in populations with generalized HIV epidemics. No matter which input combination is used, the HIV MLT model achieves a smaller MAE among all ages and country-periods (‘All-ages’ column) compared to the four other models. The HIV MLT model, with the input combination of HIV prevalence and , shows the second lowest ‘All-ages’ MAE, second only to the input combination of HIV prevalence, child mortality, and adult mortality, which uses slightly more information as inputs. The HIV MLT model shows mean absolute errors for life expectancy of less than one year for both sexes when using child and adult mortality along with HIV prevalence as inputs, and slightly more than one year when using child mortality alone and HIV prevalence. The Log-Quad model, arguably the most accurate of the four we use for comparison, shows small errors for life expectancy at birth of less than a year but misses the age-specific mortality rates (see Figure 2). Our model also shows modest errors in predicting the probability of childhood death when using as an input; these errors are about 1.3 and 1.2 percentage points for the male and female models respectively. The error in predicting the probability of adult death is slightly higher than for childhood death at around 2 percentage points for both sexes.
The key advantage of this model is its ability to produce the accentuated adult mortality humps associated with a generalized HIV epidemic. Figure 2 plots the predicted schedule from the HIV MLT model along with the WHO, Coale and Demeny, UN, and Log-Quad fits for Lesotho females in 2005–2010. Figure 2 makes clear that when HIV prevalence is high and the HIV hump is present, the HIV MLT model is able to reproduce age-specific mortality accurately. Additional selected fits can be found in Figures S1, S2, S3, and S4. The MAE by prevalence from an in-sample validation where we fit each of the 320 mortality schedules with the model described in this paper and the four comparison models is shown in Table S5 and Figure S5. This in-sample exercise shows that the HIV MLT model performs consistently at various prevalence levels and is able to outperform the four comparison models at very high HIV prevalence.
We have presented a flexible, parsimonious model of age-specific mortality for countries with generalized HIV epidemics. First, a set of age-specific mortality rates is represented as the weighted combination of a set of age-varying components. Next, the weights are modeled as a function of mortality indicators and HIV prevalence. This structure allows us to map HIV prevalence combined with other mortality indicator(s) onto a set of age-specific mortality rates reflecting the impact of a generalized HIV epidemic.
At present, our model does not include ART coverage as an input parameter as it was not a strong predictor of any of the weights. Although life expectancy at birth () likely captures at least some of the relationship between ART coverage and age-specific mortality rates, as ART coverage becomes more widespread (thus increasing the variation in ART coverage across countries and time periods), capturing both effects with just may become more problematic. Fortunately, the model structure is flexible enough to include other relevant, population-level covariates such as ART coverage or GDP if and when these quantities are available.
Results from a cross-validation experiment suggest that a three-component model fits best with modest errors for several mortality indicators. The cross validation results show that our model is able to predict age-specific mortality for countries with generalized HIV epidemics better than existing model life table systems. Combined with the outputs of existing epidemiological and demographic models, this model makes it possible to estimate future mortality profiles for countries with generalized HIV epidemics. The method also makes it possible to use other mortality indicators as well as social or economic variables to model the weights and hence predict age-specific mortality.
Because the comprehensive empirical data necessary to calibrate this model do not exist, we have been forced to compromise and use modeled mortality data produced by the UNPD. One consequence is that our model reproduces the variability in HIV prevalence-sex-age-specific mortality embodied in the UNPD life tables. Insofar as they are correctly related to the empirical ‘truth’ and cover the full range of possible HIV prevalence-sex-age-specific mortality, then our model does so too. Whatever variation is not included in the UNPD life tables is also not included in our model. This is an important limitation of this work, but we feel it is justified in light of the urgent and consequential need for a model of this type, especially for use by the UNPD. We are confident that the model is ‘fit for purpose’ in the context of the UNPD’s requirement to produce population projections for countries with high HIV prevalence. To address this limitation, the next phase of this work will involve creation of the empirical data set that we need, working in collaboration with the INDEPTH and ALPHA networks of health and demographic and HIV surveillance sites in Africa and Asia that do have the data that we need in raw form.
We have released an R package, HIV.LifeTables , that implements the model described in this paper, and we will continue to develop and improve that package. The package is available as a standard R package from the Comprehensive R Archive Network (CRAN) that can be run using the R statistical software.
Fits of HIV MLT model with three different input combinations to Swaziland female five-year life tables 1980–2010. 1) HIV prevalence with life expectancy at birth [solid black line] 2) HIV prevalence and child mortality [dotted black line] 3) HIV prevalence with child mortality and adult mortality [dashed black line]. For comparison, fits from the WHO modified logit model [red solid line], Coale and Demeny model life tables [green solid line], UN model life tables for developing countries [teal solid line], and the Log-Quad model [purple solid line] are also shown.
Fits of HIV MLT model with three different input combinations to Ghana female five-year life tables 1980–2010. 1) HIV prevalence with life expectancy at birth [solid black line] 2) HIV prevalence and child mortality [dotted black line] 3) HIV prevalence with child mortality and adult mortality [dashed black line]. For comparison, fits from the WHO modified logit model [red solid line], Coale and Demeny model life tables [green solid line], UN model life tables for developing countries [teal solid line], and the Log-Quad model [purple solid line] are also shown.
Fits of HIV MLT model with three different input combinations to Haiti male five-year life tables 1980–2010. 1) HIV prevalence with life expectancy at birth [solid black line] 2) HIV prevalence and child mortality [dotted black line] 3) HIV prevalence with child mortality and adult mortality [dashed black line]. For comparison, fits from the WHO modified logit model [red solid line], Coale and Demeny model life tables [green solid line], UN model life tables for developing countries [teal solid line], and the Log-Quad model [purple solid line] are also shown.
Fits of HIV MLT model with three different input combinations to South Africa male five-year life tables 1980–2010. 1) HIV prevalence with life expectancy at birth [solid black line] 2) HIV prevalence and child mortality [dotted black line] 3) HIV prevalence with child mortality and adult mortality [dashed black line]. For comparison, fits from the WHO modified logit model [red solid line], Coale and Demeny model life tables [green solid line], UN model life tables for developing countries [teal solid line], and the Log-Quad model [purple solid line] are also shown.
Mean Absolute Error for ages 0–75 for all model life table systems by sub-ranges of HIV prevalence. Y-axis scaled to be per 1,000.
First three left singular vectors from the Singular Value Decomposition of the matrix of mortality rates from WPP 2010 for the 40 countries experiencing a generalized HIV epidemic. from Equation 1 and plotted in Figure 3.
Coefficients for modeled weights as a function of and prevalence. Given values of and prevalence, these models will produce weights that when inserted into Equation 1 will produce a complete set of age-specific mortality rates.
Coefficients for modeled weights as a function of and prevalence. Given values of and prevalence, these models will produce weights that when inserted into Equation 1 will produce a complete set of age-specific mortality rates.
Coefficients for modeled weights as a function of , , and prevalence. Given values of , , and prevalence, these models will produce predicted weights that when inserted into Equation 1 will produce a complete set of age-specific mortality rates.
Mean Absolute Error for ages 0–75 for all model life table systems by sub-ranges of HIV prevalence. HIV prevalence ranges are shown at the top of each column. All numbers in this table are per 1,000.
The authors are grateful to Patrick Gerland and the members of the BayesPop Working Group, Center for Statistics and the Social Sciences, University of Washington for invaluable discussion during the preparation of this work.
Conceived and designed the experiments: DJS SJC AER. Performed the experiments: DJS. Analyzed the data: DJS. Wrote the paper: DJS AER SJC.
- 1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2013) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. The Lancet 380: 2095–2128.
- 2. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, et al. (2013) Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the global burden of disease study 2010. The Lancet 380: 2071–2094.
- 3. Mathers C, Fat D, Inoue M, Rao C, Lopez A (2005) Counting the dead and what they died from: an assessment of the global status of cause of death data. Bulletin of the World Health Organization 83: 171–177.
- 4. Raftery AE, Chunn JL, Gerland P, Ševčíková H (2013) Bayesian probabilistic projections of life expectancy for all countries. Demography 50: 777–801.
- 5. Sharrow D, Clark SJ, Collinson M, Kahn K, Tollman S (2013) The age pattern of increases in mortality affected by HIV: Bayesian fit of the Heligman-Pollard Model to data from the Agincourt HDSS field site in rural northeast South Africa. Demographic Research 29: 1039–1096.
- 6. Ngom P, Clark SJ (2003) Adult mortality in the era of HIV/AIDS: sub-Saharan Africa. Technical report, Population Division, United Nations, New York.
- 7. Blacker J (2004) The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS 18: S19–S26.
- 8. Timaeus IM, Jasseh M (2004) Adult mortality in sub-Saharan Africa: Evidence from Demographic and Health Surveys. Demography 41: 757–772.
- 9. Porter K, Zaba B (2004) The empirical evidence for the impact of HIV on adult mortality in the developing world: data from serological studies. AIDS 18: S9–S17.
- 10. Obermeyer Z, Rajaratnam JK, Park CH, Gakidou E, Hogan MC, et al.. (2010) Measuring adult mortality using sibling survival: A new analytical method and new results for 44 countries, 1974–2006. PLoS Medicine 7.
- 11. Ghys PD, Brown T, Grassly N, Garnett G, Stanecki K, et al. (2004) The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sexually Transmitted Infections 80: i5–i9.
- 12. Heuveline P, Clark SJ (2011) International handbook of adult mortality, Springer, volume 2, chapter 24: Model Schedules of Mortality. 511–532.
- 13. Guillot M, Gerland P, Pelletier F, Saabneh A (2012) Child mortality estimation: a global overview of infant and child mortality age patterns in light of new empirical data. PLoS Medicine 9.
- 14. Wilmoth J, Zureick S, Canudas-Romo V, Inoue M, Sawyer C (2012) A flexible two-dimensional mortality model for use in indirect estimation. Population Studies 66: 1–28.
- 15. Coale AJ, Demeny P (1966) Regional Model Life Tables and Stable Populations. Princeton University Press.
- 16. Coale AJ, Demeny P, Vaughan B (1983) Regional Model Life Tables and Stable Populations. Academic Press New York, 2nd edition.
- 17. United Nations Department of International Economic and Social Affairs (1982) Model life tables for developing countries. New York: United Nations.
- 18. Murray CJL, Ferguson BD, Lopez AD, Guillot M, Salomon JA, et al. (2003) Modified logit life table system: Principles, empirical validation, and application. Population Studies 57: 165–182.
- 19. Lutz W, Samir KC (2010) Dimensions of global population projections: what do we know about future population trends and structures? Philosophical Transactions of the Royal Society of London Series B, Biological Sciences 365: 2779–91.
- 20. Raftery AE, Li N, Ševčíková H, Gerland P, Heilig GK (2012) Bayesian probabilistic population projections for all countries. Proceedings of the National Academy of Sciences of the United States of America 109: 13915–21.
- 21. Alkema L, Raftery AE, Gerland P, Clark SJ, Pelletier F, et al. (2011) Probabilistic projections of the total fertility rate for all countries. Demography 48: 815–839.
- 22. Wheldon MC, Raftery AE, Clark SJ, Gerland P (2013) Reconstructing past populations with uncertainty from fragmentary data. Journal of the American Statistical Association 108: 96–110.
- 23. Brown T, Bao L, Raftery A, Salomon J, Baggaley R, et al. (2010) Modeling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection Package 2009. Sexually Transmitted Infections 86: 3–10.
- 24. Ghys PD, Garnett GP (2010) The 2009 HIV and AIDS estimates and projections: methods, tools and analyses. Sexually Transmitted Infections 86: ii1–ii2.
- 25. United Nations, Department of Economic and Social Affairs, Population Division (2011) World Population Prospects: the 2010 Revision. New York: United Nations.
- 26. United Nations, Department of Economic and Social Affairs, Population Division (2011) World Population Prospects: the 2010 Revision, Special Tabulations.
- 27. Clark SJ (2001) An Investigation into the Impact of HIV on Population Dynamics in Africa. Ph.d., University of Pennsylvania.
- 28. INDEPTH Network [Prepared by Samuel J Clark] (2002) INDEPTH Mortality Patterns for Africa, Ottawa: IDRC Press, volume 1 of Population and Health in Developing Countries, chapter. 7: 83–128.
- 29. Raftery AE (1995) Bayesian model selection in social research. Sociological Methodology 25: 111–163.
- 30. Raftery A, Hoeting J, Volinsky C, Painter I, Yeung KY (2012) BMA: Bayesian Model Averaging. Available: http://CRAN.R-project.org/package=BMA. R package version 3.15.1.
- 31. Lee RD, Carter LR (1992) Modeling and forecasting us mortality. Journal of the American statistical association 87: 659–671.
- 32. Crum N, Riffenburgh R, Wegner S, Agan B, Tasker S, et al. (2006) Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes 41: 194–200.
- 33. Palella FJ, Baker R, Moorman A, Chmiel J, Wood K, et al. (2006) Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes (1999) 43: 27–34.
- 34. UNAIDS (2012) 2012 report on the gloabl AIDS epidemic. Technical report, UNAIDS: Geneva, Switzerland.
- 35. Sharrow DJ (2013) HIV.LifeTables: HIV calibrated model life tables for countries with generalized HIV epidemics. Available: http://CRAN.R-project.org/package=HIV.LifeTables. R package version 0.1.